Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04849871 · ClinicalTrials.gov registry record · NA

Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma

A NA study of Breast Cancer and Breast Carcinoma, sponsored by Washington University School of Medicine.

Active
Registry status
NA
Development phase
134
Enrollment target
1
Study location

NCT04849871 is a NA study of Breast Cancer and Breast Carcinoma that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 134 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04849871, a NA study of Breast Cancer and Breast Carcinoma, is active but no longer recruiting, sponsored by Washington University School of Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
134 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the local control, complication rates, cosmetic results, and quality of life between patients treated with a single fraction vs. five fractions of accelerated partial breast irradiation (S\_APBI vs. F\_APBI) when used as the sole method of radiation therapy.

Interventions

  • RADIATION External Beam Accelerated Partial Breast Irradiation

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2021-08-12
Est. Completion 2029-08-06
Phase NA

What the Registry Record Tells You About NCT04849871

The ClinicalTrials.gov registry entry for NCT04849871 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which External Beam Accelerated Partial Breast Irradiation is the first listed.

NCT04849871 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04849871 about?

NCT04849871 is a clinical study titled "Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma". This study will evaluate the local control, complication rates, cosmetic results, and quality of life between patients treated with a single fraction vs. five fractions of accelerated partial breast irradiation (S\_APBI vs. F\_APBI) when used as the sole method of radiation therapy.

What is the current status of trial NCT04849871?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2021-08-12. Estimated completion is 2029-08-06.

What conditions does trial NCT04849871 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Carcinoma, Stage I Breast Cancer, Stage 0 Breast Cancer.

What interventions are being tested in trial NCT04849871?

The interventions under investigation include: External Beam Accelerated Partial Breast Irradiation (RADIATION).

Who is sponsoring clinical trial NCT04849871?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04849871 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.